Life Expectancy and Management of Esophageal Varices

Prognosis Stratification

Patients with newly diagnosed esophageal varices who have never bled have a 5-year mortality of approximately 20% if varices are discovered as an isolated finding, but mortality exceeds 80% if varices are found alongside other decompensating events like ascites or encephalopathy 1
Compensated cirrhosis with varices is associated with a substantially better prognosis than decompensated cirrhosis 1
Decompensated cirrhosis with ascites or encephalopathy has a 5-year mortality exceeding 80% when varices are present 1
Isolated variceal finding is associated with a 5-year mortality of approximately 20% 1
Untreated patients who have experienced variceal hemorrhage have a median rebleeding rate of approximately 60% within 1-2 years, with a mortality of 33% 2
High-risk indicators, such as hepatic venous pressure gradient ≥20 mm Hg or Child-Pugh class C, are associated with significantly worse outcomes, with over 80% of Child-Pugh C patients having HVPG ≥20 mm Hg 1

The American Association for the Study of Liver Diseases recommends primary prophylaxis with nonselective beta-blockers, such as propranolol, nadolol, or carvedilol, for patients with medium or large varices who have never bled 1
Endoscopic variceal ligation (EVL) is also recommended for primary prophylaxis in patients with medium or large varices who have never bled 1
For small varices with high-risk features, such as Child B/C or red wale marks, nonselective beta-blockers should be initiated 3
Combination therapy with nonselective beta-blockers and EVL is superior to EVL alone for secondary prophylaxis in patients who have experienced variceal hemorrhage 2, 4
The American Association for the Study of Liver Diseases recommends that all patients with Child-Pugh score ≥7 or MELD score ≥15 who survive variceal hemorrhage should be referred for liver transplantation evaluation 2

For patients who decline or cannot tolerate prophylactic therapy, surveillance endoscopy should be performed every 2 years for small varices if compensated, and annually if decompensated 3
For patients with no varices, surveillance endoscopy should be performed every 2-3 years if compensated, and annually if decompensated 3

Variceal size is an independent predictor of hemorrhage and mortality, with large varices having a 15% yearly bleeding risk 3
Red color signs, such as red wale marks or cherry red spots, dramatically increase bleeding risk to 80% 3
Degree of hepatic decompensation, as measured by Child-Pugh class and presence of ascites or encephalopathy, is the strongest predictor of mortality 1